IMARC Group, a leading market research company, has recently releases report titled “Transdermal Drug Delivery Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027.” The study provides a detailed analysis of the industry, including the global transdermal drug delivery systems market share, size, trends, and growth forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market.

How big is the transdermal drug delivery systems market?

The global transdermal drug delivery systems market size reached US$ 6.0 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.7 Billion by 2027, exhibiting a growth rate (CAGR) of 6.36% during 2022-2027.

What are transdermal drug delivery systems?

A transdermal drug delivery system is a method that allows drugs to be absorbed through the skin for therapeutic purposes. It offers a convenient and non-invasive alternative to traditional drug delivery systems, such as injections, oral medications, and subcutaneous and transmucosal methods. It provides consistent and controlled drug release over an extended period, due to which it is particularly used in treating Alzheimer's disease, Parkinson's disease, and depression. It is also widely employed in hormone and nicotine replacement therapy. Currently, matrix and reservoir systems represent the two primary types of transdermal drug delivery systems available in the market.

Note: We are in the process of updating our reports. If you want to receive the latest research data covering the time period from 2023 to 2028, along with industry trends, market size, and competitive analysis, click on the request sample report. The team would be able to deliver the latest version of the report in a quick turnaround time.

Get the Sample Report: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market/requestsample

What are the recent trends in transdermal drug delivery systems?

The increasing demand for non-invasive drug delivery methods and the rising geriatric population are some of the key factors bolstering the market growth. The growing cases of chronic conditions, such as pain, arthritis, and hormone imbalances, and escalating consumer awareness about the benefits of transdermal drug delivery systems, such as consistent and controlled drug release, are providing an impetus to the market growth. Other factors, such as burgeoning research and development (R&D) activities, the surging number of clinical trials for transdermal drug delivery systems, and rising demand for home healthcare services, are accelerating the market growth.

Transdermal Drug Delivery Systems Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape with Key Players:

The competitive landscape of the global transdermal drug delivery systems market has been studied in the report with the detailed profiles of the key players operating in the market.

Key Companies:

• 3M Company
• Acrux Limited 
• Boehringer Ingelheim International GmbH
• Hisamitsu Pharmaceutical Co. Inc. 
• Lavipharm S.A. 
• LEAD CHEMICAL Co. Ltd.
• Luye Pharma Group 
• Nutriband Inc. 
• Viatris Inc. 

Key Market Segmentation:

The report has segmented the global transdermal drug delivery systems market on the basis of technology, application and region.

Breakup by Technology:

• Electroporation
• Radiofrequency
• Iontophoresis
• Microporation
• Thermal
• Mechanical Arrays
• Ultrasound
• Others

Breakup by Application:

• Central Nervous System
• Pain Management
• Cardiovascular
• Hormone
• Others

Geographical Analysis:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Explore Full Report Description At: https://www.imarcgroup.com/transdermal-drug-delivery-systems-market

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Market Trends
• Market Drivers and Success Factors
• Impact of COVID-19
• Value Chain Analysis
• Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us                                    

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Media Contact:
Company Name: IMARC Group
Contact Person: Elena Anderson
Email: sales@imarcgroup.com
Phone: +1-631-791-1145
Address: 134 N 4th St
City: Brooklyn
State: NY
Country: United States
Website: https://www.imarcgroup.com